{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:48:49Z","timestamp":1787662129148,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd001415.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000}}],"reference-count":40,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001415.pub3","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T20:59:32Z","timestamp":1540414772000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gabapentin add-on treatment for drug-resistant focal epilepsy"],"prefix":"10.1002","author":[{"given":"Mariangela","family":"Panebianco","sequence":"first","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Al-Bachari","sequence":"additional","affiliation":[{"name":"Royal Preston Hospital; Department of Neurology; Sharoe Green Lane North Fulwood Preston Lancashire UK PR2 9HT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Weston","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane L","family":"Hutton","sequence":"additional","affiliation":[{"name":"University of Warwick; Department of Statistics; Coventry UK CV4 7AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD001415.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1528-1157.1994.tb02513.x","article-title":"Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study","volume":"35","author":"Anhut","year":"1994","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD001415.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1528-1157.1999.tb00833.x","article-title":"Gabapentin as add-on therapy in children with refractory partial seizures: a 12 week, multicentre, double blind placebo controlled study","volume":"40","author":"Appleton","year":"1999","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.56.6.743","article-title":"Rapid Initiation of gabapentin: a randomised control trial","volume":"56","author":"Fisher","year":"2001","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD001415.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/WNL.0000000000003118","article-title":"Adjunctive pregabalin vs gabapentin for focal seizures: Interpretation of comparative outcomes","volume":"87","author":"French","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD001415.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jnnp.62.4.372","article-title":"Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy","volume":"62","author":"Leach","year":"1997","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD001415.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1528-1157.2000.tb04607.x","article-title":"Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomised, double-blind, dose titration study","volume":"41","author":"Lindberger","year":"2000","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD001415.pub3-BIB0007|cit7","first-page":"359","article-title":"Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine","volume":"50","author":"Sethi","year":"2002","journal-title":"Neurology India"},{"issue":"4","key":"10.1002\/14651858.CD001415.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1528-1157.1991.tb04689.x","article-title":"Double blind study of gabapentin in the treatment of partial seizures","volume":"32","author":"Sivenius","year":"1991","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD001415.pub3-BIB0009|cit9","first-page":"151","article-title":"Gabapentin as adjuvant therapy in the treatment of refractory partial epilepsy","volume":"56","author":"Tomovic","year":"1999","journal-title":"Vojnosanit Pregl"},{"issue":"8698","key":"10.1002\/14651858.CD001415.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0140-6736(90)91123-R","article-title":"Gabapentin in partial epilepsy","volume":"335","author":"UK Gabapentin Study Group","year":"1990","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD001415.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1212\/WNL.43.11.2292","article-title":"Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study","volume":"43","author":"US Gabapentin Study Group No 5","year":"1993","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD001415.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1440-1819.2006.01553.x","article-title":"Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study","volume":"60","author":"Yamauchi","year":"2006","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"4","key":"10.1002\/14651858.CD001415.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40263-013-0048-z","article-title":"Pharmacotherapy of focal epilepsy in children: a systematic review of approved agents","volume":"27","author":"Arya","year":"2013","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1002\/14651858.CD001415.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bcp.12083","article-title":"Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials","volume":"76","author":"Bodalia","year":"2013","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD001415.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/jnnp.50.6.682","article-title":"Gabapentin as an antiepileptic drug in man","volume":"50","author":"Crawford","year":"1987","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001415.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/epi.12913","article-title":"Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trial","volume":"56","author":"Jacoby","year":"2015","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD001415.pub3-BIB0017|cit17","first-page":"19","article-title":"Comparative clinical trial of gabapentin and sodium valproate as add-on therapy in refractory partial epilepsies: open randomized multicenter trial","volume":"4","author":"Korean Gabapentin Study Group","year":"2000","journal-title":"Journal of Korean Epilepsy Society"},{"issue":"3","key":"10.1002\/14651858.CD001415.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.braindev.2013.04.006","article-title":"The efficacy of gabapentin in children of partial seizures and the blood levels","volume":"36","author":"Nonoda","year":"2014","journal-title":"Brain & Development"},{"issue":"5","key":"10.1002\/14651858.CD001415.pub3-BIB0019|cit19","first-page":"931","article-title":"New antiepileptic drugs: characteristics and clinical applications","volume":"72","author":"Ohtsuka","year":"2014","journal-title":"Japanese Journal of Clinical Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001415.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1684\/epd.2014.0650","article-title":"Early add-on treatment vs alternative monotherapy in patients with partial epilepsy","volume":"16","author":"Semah","year":"2014","journal-title":"Epileptic Disorders"},{"issue":"Suppl","key":"10.1002\/14651858.CD001415.pub3-BIB0021|cit21","first-page":"69","article-title":"A double blind study of gabapentin in partial seizures","volume":"41","author":"Kwan","year":"2000","journal-title":"Epilepsia"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD001415.pub3-BIB0022|cit22","first-page":"106","article-title":"Gabapentin as add-on therapy for refractory partial seizures in children 1-36 months of age: a novel, short-term, placebo-controlled trial","volume":"41","author":"Shapiro","year":"2000","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-94-017-8914-1_24","article-title":"What are the arguments for and against rational therapy for epilepsy?","volume":"813","author":"Barker-Haliski","year":"2014","journal-title":"Advances in Experimental Medicine & Biology"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0024|cit24","unstructured":"British National Formulary www.bnf.org\/"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the national general practice study of epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0026|cit26","unstructured":"GRADE Working Group, McMaster University GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0028|cit28","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0030|cit30","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org\/"},{"issue":"3","key":"10.1002\/14651858.CD001415.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-6147(00)01974-X","article-title":"Current status and future directions in the pharmacotherapy of epilepsy","volume":"23","author":"Loscher","year":"2002","journal-title":"Trends in Pharmacological Sciences"},{"issue":"2","key":"10.1002\/14651858.CD001415.pub3-BIB0032|cit32","first-page":"72","article-title":"Gabapentin","volume":"36 Suppl","author":"McClean","year":"1995","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0033|cit33","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized Linear Models","author":"McCullagh","year":"1989"},{"issue":"4","key":"10.1002\/14651858.CD001415.pub3-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002896.pub2","article-title":"Vagus nerve stimulation for partial seizures","author":"Panebianco","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1528-1157.1981.tb06158.x","article-title":"Phenytoin for epilepsy: a long term prospective study, assisted by serum level monitoring in previously untreated patients","volume":"22","author":"Reynolds","year":"1981","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD001415.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001415.pub3-BIB0037|cit37","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A editor(s) Grade Working Group GRADE handbook for grading quality of evidence and strength of recommendations Available from www.guidelinedevelopment.org\/handbook 2013"},{"issue":"7","key":"10.1002\/14651858.CD001415.pub3-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010541.pub2","article-title":"Surgery for epilepsy","author":"West","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD001415.pub3-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001415.pub2","article-title":"Gabapentin add-on for drug-resistant partial epilepsy","author":"Al-Bachari","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001415.pub3-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001415","article-title":"Gabapentin add-on for drug-resistant partial epilepsy","author":"Marson","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001415.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001415.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:02:45Z","timestamp":1628542965000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001415.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001415.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001415.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,24]]}}}